01-BMT-137: A Phase 2 Open Label, Randomized, Dose and Schedule Finding, Clinical Trial of Immunotherapy with AMG 412 in Subjects with Diffuse Large B-Cell Non-Hodgkin's LymphomRa

  • Howard, Dianna (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/5/022/28/03